UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 17 filers reported holding UNICYCIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 3,470,152 | $2,984,331 | 0.33% |
Nantahala Capital Management | 3,470,541 | $2,984,666 | 0.26% |
BVF INC/IL | 3,413,563 | $2,935,664 | 0.08% |
RA Capital Management | 3,470,688 | $2,984,792 | 0.06% |
TANDEM CAPITAL MANAGEMENT CORP /ADV | 31,000 | $26,660 | 0.01% |
Virtu Financial LLC | 10,994 | $9 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 52,399 | $45,063 | 0.00% |
STATE STREET CORP | 35,036 | $30,131 | 0.00% |
GOLDMAN SACHS GROUP INC | 93,233 | $80,180 | 0.00% |
TWO SIGMA SECURITIES, LLC | 11,165 | $9,602 | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 18,800 | $16,168 | 0.00% |
Beacon Pointe Advisors, LLC | 11,861 | $10,200 | 0.00% |
Tower Research Capital LLC (TRC) | 3,068 | $2,638 | 0.00% |
VANGUARD GROUP INC | 115,057 | $98,949 | 0.00% |
UBS Group AG | 718 | $617 | 0.00% |
WELLS FARGO & COMPANY/MN | 39 | $34 | 0.00% |
This page lists UNICYCIVE THERAPEUTICS INC's shareholders in Q3 2023. To view UNICYCIVE THERAPEUTICS INC's shareholder history, click here.